A RANDOMIZED, CONTROLLED TRIAL OF INTRANASAL OXYTOCIN AS AN ADJUNCT TO BEHAVIORAL THERAPY FOR AUTISM SPECTRUM DISORDER

$1,159,063FY2012Department of the ArmyDOD

The General Hospital Corporation

Investigators